ATE465173T1 - Verändertes vp-1capsidprotein von parvovirus b19 - Google Patents
Verändertes vp-1capsidprotein von parvovirus b19Info
- Publication number
- ATE465173T1 ATE465173T1 AT05799042T AT05799042T ATE465173T1 AT E465173 T1 ATE465173 T1 AT E465173T1 AT 05799042 T AT05799042 T AT 05799042T AT 05799042 T AT05799042 T AT 05799042T AT E465173 T1 ATE465173 T1 AT E465173T1
- Authority
- AT
- Austria
- Prior art keywords
- parvovirus
- protein
- 1capsid
- altered
- capsid protein
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14211—Erythrovirus, e.g. B19 virus
- C12N2750/14222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP04450180 | 2004-09-24 | ||
| PCT/EP2005/054771 WO2006032697A2 (en) | 2004-09-24 | 2005-09-23 | MODIFIED VPl-CAPSID PROTEIN OF PARVOVIRUS B19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE465173T1 true ATE465173T1 (de) | 2010-05-15 |
Family
ID=35809798
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05799042T ATE465173T1 (de) | 2004-09-24 | 2005-09-23 | Verändertes vp-1capsidprotein von parvovirus b19 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US9573979B2 (de) |
| EP (2) | EP1791858B1 (de) |
| AT (1) | ATE465173T1 (de) |
| CY (1) | CY1110185T1 (de) |
| DE (1) | DE602005020815D1 (de) |
| ES (2) | ES2556710T3 (de) |
| PL (1) | PL1791858T3 (de) |
| PT (1) | PT1791858E (de) |
| WO (1) | WO2006032697A2 (de) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090215879A1 (en) * | 2008-02-26 | 2009-08-27 | University Of North Carolina At Chapel Hill | Methods and compositions for adeno-associated virus (aav) with hi loop mutations |
| US8889641B2 (en) | 2009-02-11 | 2014-11-18 | The University Of North Carolina At Chapel Hill | Modified virus vectors and methods of making and using the same |
| US9744228B2 (en) | 2010-04-07 | 2017-08-29 | Norvartis Ag | Method for generating a parvovirus B19 virus-like particle |
| EP2446898A1 (de) * | 2010-09-30 | 2012-05-02 | Laboratorios Del. Dr. Esteve, S.A. | Verwendung von Wachstumshormonen zur Verbesserung der Immunantwort bei immunsupprimierten Patienten |
| WO2012055814A1 (en) | 2010-10-25 | 2012-05-03 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Compound inducing lbpa accumulation for inhibiting cell-to-cell transmission of hiv |
| EP2729165B1 (de) | 2011-07-06 | 2017-11-08 | GlaxoSmithKline Biologicals SA | Immunogene kombinationszusammensetzungen und ihre verwendung |
| US10030052B2 (en) * | 2011-07-25 | 2018-07-24 | Glaxosmithkline Biologicals Sa | Parvovirus Vp1 unique region polypeptides and compositions thereof |
| ES2941502T3 (es) | 2016-05-13 | 2023-05-23 | 4D Molecular Therapeutics Inc | Variantes de cápsides de virus adenoasociado y procedimientos de utilización de las mismas |
| CR20200165A (es) | 2017-09-20 | 2020-06-05 | 4D Molecular Therapeutics Inc | Variantes de cápsides de virus adenoasociados y métodos de uso de estas |
| AU2018372235B9 (en) | 2017-11-27 | 2022-03-10 | 4D Molecular Therapeutics Inc. | Adeno-associated virus variant capsids and use for inhibiting angiogenesis |
| CN113474461A (zh) | 2019-02-25 | 2021-10-01 | 诺华股份有限公司 | 治疗bietti晶体营养不良的组合物和方法 |
| AU2020229085A1 (en) | 2019-02-25 | 2021-08-19 | Friedrich Miescher Institute For Biomedical Research | Compositions and methods to treat bietti crystalline dystrophy |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0468520A3 (en) | 1990-07-27 | 1992-07-01 | Mitsui Toatsu Chemicals, Inc. | Immunostimulatory remedies containing palindromic dna sequences |
| WO1995026204A1 (en) | 1994-03-25 | 1995-10-05 | Isis Pharmaceuticals, Inc. | Immune stimulation by phosphorothioate oligonucleotide analogs |
| ES2267100T5 (es) | 1994-07-15 | 2011-04-08 | The University Of Iowa Research Foundation | Oligonucleótidos inmunomoduladores. |
| US6207646B1 (en) | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| RS50101B (sr) | 1996-02-24 | 2009-01-22 | Boehringer Ingelheim International Gmbh., | Farmaceutski preparati za imunomodulaciju |
| JP4111403B2 (ja) | 1996-10-11 | 2008-07-02 | ザ リージェンツ オブ ザ ユニバーシティー オブ カリフォルニア | 免疫刺激ポリヌクレオチド／免疫調節分子複合体 |
| CA2281838A1 (en) | 1997-02-28 | 1998-09-03 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated cpg dinucleotide in the treatment of lps-associated disorders |
| WO1998040100A1 (en) | 1997-03-10 | 1998-09-17 | Ottawa Civic Loeb Research Institute | USE OF NUCLEIC ACIDS CONTAINING UNMETHYLATED CpG DINUCLEOTIDE AS AN ADJUVANT |
| JP2001526688A (ja) | 1997-05-19 | 2001-12-18 | メルク エンド カンパニー インコーポレーテッド | オリゴヌクレオチドアジュバント |
| US6339068B1 (en) | 1997-05-20 | 2002-01-15 | University Of Iowa Research Foundation | Vectors and methods for immunization or therapeutic protocols |
| DE19803453A1 (de) | 1998-01-30 | 1999-08-12 | Boehringer Ingelheim Int | Vakzine |
| CA2323929C (en) | 1998-04-03 | 2004-03-09 | University Of Iowa Research Foundation | Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| WO1999056755A1 (en) | 1998-05-06 | 1999-11-11 | University Of Iowa Research Foundation | Methods for the prevention and treatment of parasitic infections and related diseases using cpg oligonucleotides |
| SE520177C2 (sv) * | 1998-11-24 | 2003-06-03 | Kristina Broliden | Användning av tomma, icke-infektiösa, rekombinanta parvoviruskapsidpartiklar, eller P-antigenblockerande delar därav, för framställning av läkemedel för ihibering av hematopoietiska stamceller |
| AT408721B (de) | 1999-10-01 | 2002-02-25 | Cistem Biotechnologies Gmbh | Pharmazeutische zusammensetzung enthaltend ein antigen |
| WO2002013857A2 (en) | 2000-08-17 | 2002-02-21 | Intercell Biomedizinische Forschungs- Und Entwicklungs Ag | A vaccine which comprises at least one antigen and a cathelididin derived antimicrobial peptide or a derivative thereof |
| AT410635B (de) | 2000-10-18 | 2003-06-25 | Cistem Biotechnologies Gmbh | Vakzin-zusammensetzung |
| EP1275658B1 (de) * | 2001-07-10 | 2006-11-15 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Zusammensetzung einer Parvovirus VP1-Proteinvariante und eines arvovirus NS1-Proteins zur Induktion von Zytolyse |
-
2005
- 2005-09-23 EP EP05799042A patent/EP1791858B1/de not_active Not-in-force
- 2005-09-23 DE DE602005020815T patent/DE602005020815D1/de active Active
- 2005-09-23 PL PL05799042T patent/PL1791858T3/pl unknown
- 2005-09-23 PT PT05799042T patent/PT1791858E/pt unknown
- 2005-09-23 US US11/575,951 patent/US9573979B2/en not_active Expired - Fee Related
- 2005-09-23 EP EP09174552.1A patent/EP2149583B1/de not_active Not-in-force
- 2005-09-23 ES ES09174552.1T patent/ES2556710T3/es active Active
- 2005-09-23 ES ES05799042T patent/ES2344739T3/es active Active
- 2005-09-23 WO PCT/EP2005/054771 patent/WO2006032697A2/en active Application Filing
- 2005-09-23 AT AT05799042T patent/ATE465173T1/de active
-
2010
- 2010-07-13 CY CY20101100651T patent/CY1110185T1/el unknown
-
2017
- 2017-01-18 US US15/408,485 patent/US20170260239A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ES2344739T3 (es) | 2010-09-06 |
| WO2006032697A2 (en) | 2006-03-30 |
| EP1791858A2 (de) | 2007-06-06 |
| PT1791858E (pt) | 2010-07-26 |
| ES2556710T3 (es) | 2016-01-19 |
| WO2006032697A3 (en) | 2006-05-18 |
| EP2149583B1 (de) | 2015-10-28 |
| DE602005020815D1 (de) | 2010-06-02 |
| CY1110185T1 (el) | 2015-01-14 |
| EP1791858B1 (de) | 2010-04-21 |
| US20070286870A1 (en) | 2007-12-13 |
| EP2149583A1 (de) | 2010-02-03 |
| PL1791858T3 (pl) | 2010-09-30 |
| US20170260239A1 (en) | 2017-09-14 |
| US9573979B2 (en) | 2017-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE465173T1 (de) | Verändertes vp-1capsidprotein von parvovirus b19 | |
| DE60235761D1 (de) | Isoform des vegfs | |
| CY1111225T1 (el) | Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c | |
| CY1109382T1 (el) | ΠΑΡΑΛΛΑΓΕΣ ΠΕΡΙΟΧΗΣ Fc | |
| IL180727A0 (en) | Antimicrobial peptides comprising an arginine and/or lysine -containing motif | |
| ATE471370T1 (de) | Varianten von beta-glukosidasen | |
| BR0307702A (pt) | Formulações de solução contendo anticorpo | |
| CY1111212T1 (el) | Θειικες ενωσεις ως αναστολεις της πρωτεασης σερινης ns3 του ιου της ηπατιτιδας γ | |
| CY1108655T1 (el) | ΘΕΙΟΖΟΛΙΔΙΝ-4-ΟΝΕΣ ΓΙΑ ΤΗΝ ΑΝΑΣΤΟΛΗ ΠΡΩΤΕΪΝΩΝ hYAK3 | |
| DE60322188D1 (de) | Zytokin (zcytor17-ligand) | |
| ATE434662T1 (de) | Acetolactatsynthase codierende gene | |
| DE60137587D1 (de) | Antimikrobielle peptide und deren verwendung | |
| ATE446972T1 (de) | Il-1 bindende antikörper und fragmente davon | |
| ATE391781T1 (de) | Transgenes tier welches das trunkierte alzheimer tau protein exprimiert | |
| DK1608745T3 (da) | FVII eller FVIIa-Varianter | |
| EA200800098A1 (ru) | Экспрессионный вектор и способ продуцирования высоких уровней белков | |
| ATE527280T1 (de) | Fluoreszentprotein und chromoprotein | |
| EP1801232A4 (de) | Verfahren zum screening eines transmembranenzymhemmstoffs | |
| ATE421698T1 (de) | Intrinsic-faktor vom schwein | |
| DK1602721T3 (da) | Phospholipase A SB 2 /SB stammende fra Koji-skimmelsvamp | |
| ATE511644T1 (de) | Neues screening-verfahren | |
| ATE397753T1 (de) | Screening-verfahren für eine prophylaktische und therapeutische substanz für eine nierenerkrankung | |
| WO2007073845A8 (en) | Polypeptide having esterase activity and recombinant esterase and use thereof | |
| ATE362984T1 (de) | Neuartige proteine und deren dna | |
| WO2005003289A3 (en) | Ap1 amine oxidase variants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1791858 Country of ref document: EP |